Bulletin
Investor Alert

Market Pulse Archives

Nov. 20, 2019, 4:55 p.m. EST

Shares of Neon Therapeutics rise on restructuring plans

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Neon Therapeutics Inc. (NTGN)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Neon Therapeutics /zigman2/quotes/204002731/composite NTGN +6.38% were up 19% in after-hours trading Wednesday after the company announced a corporate restructuring that includes cutting 24% of its workforce. Neon, which employs about 100 workers, now plans to focus on developing T-cell therapies and is halting new spending on its cancer vaccine programs. The Cambridge, Mass.-based biotech said it expects $35 million in annualized cost savings, and severance and restructuring charges will result in pre-tax charges of $1.5 million. Shares of Neon have tumbled 71% year-to-date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.91% is up 24%.

/zigman2/quotes/204002731/composite
US : U.S.: Nasdaq
$ 1.00
+0.06 +6.38%
Volume: 194,995
Dec. 6, 2019 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$28.34 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,145.91
+28.48 +0.91%
Volume: 1.70B
Dec. 6, 2019 5:07p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.